Travere Therapeutics Inc (TVTX) USD0.0001
Sell:$17.25Buy:$21.50
$0.70
(3.97%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$17.25
Buy:$21.50
Change:$0.70
(3.97%)
$0.70
(3.97%)Prices delayed by at least 15 minutes
Sell:$17.25
Buy:$21.50
Change:$0.70
(3.97%)
$0.70
(3.97%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 April 2025 | Christopher R (Chris) ClineCFO | Sell Tax related | 48 | $13.14 | $630.94 | 89,990 |
| 12 February 2025 | Peter HeermaChief Level Officer | Sell Tax related | 2,568 | $23.53 | $60,425.55 | 125,066 |
| 12 February 2025 | William E RoteSenior Vice President | Sell Tax related | 5,200 | $23.53 | $122,356.00 | 98,519 |
| 12 February 2025 | Jula K InrigOther Level A | Sell Tax related | 2,568 | $23.53 | $60,425.55 | 89,602 |
| 12 February 2025 | Elizabeth E ReedCompany Secretary | Sell Option/Award related | 8,000 | $23.53 | $188,240.00 | 89,482 |
| 11 February 2025 | Eric M DubePresident/CEO | Sell Regular sell transaction (market) | 11,375 | $24.04 | $273,455.00 | 419,173 |
| 11 February 2025 | Peter HeermaChief Level Officer | Sell Option/Award related | 3,074 | $25.00 | $76,850.00 | 127,634 |
| 11 February 2025 | Sandra (Sandy) CalvinChief Accounting Officer | Sell Option/Award related | 10,000 | $25.00 | $250,000.00 | 63,654 |
| 11 February 2025 | Sandra (Sandy) CalvinChief Accounting Officer | Sell Option/Award related | 10,000 | $25.00 | $250,000.00 | 63,654 |
| 11 February 2025 | Sandra (Sandy) CalvinChief Accounting Officer | Sell Option/Award related | 10,000 | $25.00 | $250,000.00 | 63,654 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 February 2025 | Eric M DubePresident/CEO | Sell Tax related | 50,691 | $20.21 | $1,024,343.45 | 430,548 |
| 30 September 2024 | Jeffrey A MecklerIndependent Director | Sell Option/Award related | 40,000 | $14.06 | $562,324.00 | 81,000 |
| 11 February 2025 | Sandra (Sandy) CalvinChief Accounting Officer | Sell Option/Award related | 15,000 | $25.00 | $375,000.00 | 63,654 |
| 23 January 2025 | Roy D BaynesIndependent Director | Sell Option/Award related | 16,000 | $20.00 | $320,000.00 | 31,000 |
| 4 October 2024 | Gary A LyonsChairman of the Board | Sell Option/Award related | 21,179 | $14.35 | $303,874.17 | 69,821 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.